Discover 1,707 paid clinical trials in Bloomfield Hills, Michigan. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,707
TR(ACE) Assay Clinical Specimen Study
for
Carcinoma, Non-Small-Cell Lung, Breast Neoplasms
Location: Port Huron MI, Canton OH, Bloomington IN,
Sponsor: Biological Dynamics
Sex: All
Age: 21+
Code: NCT02934360
Recruiting
The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
for
Sickle Cell Disease
Location: Ann Arbor MI, Chicago IL, Indianapolis IN, Baltimore MD,
Sponsor: Sanofi
Sex: All
Age: 10 - 65
Code: NCT06975865
Phase3, Recruiting
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
for
Breast Cancer, Breast Cancer Metastatic,
Location: Detroit MI, Fort Wayne IN, Canton OH, Buffalo NY,
Sponsor: Incyclix Bio
Sex: All
Age: 18+
Code: NCT05735080
Phase1, Phase2, Recruiting
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
for
Atrial Fibrillation, Stroke, Bleeding
Location: Ann Arbor MI, London, Cleveland OH, Toronto,
Sponsor: Icahn School of Medicine at Mount Sinai
Sex: All
Age: 18+
Code: NCT04045665
Phase3, Recruiting
A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer
for
Squamous Cell Carcinoma of Head and Neck
Location: Detroit MI, Ann Arbor MI, Cleveland OH, Chicago IL,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06385080
Phase1, Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Rare and Atypical Diabetes Network
for
Diabetes Mellitus, Diabetes Mellitus Progression,
Location: Ann Arbor MI, Chicago IL, Indianapolis IN, Baltimore MD,
Sponsor: University of South Florida
Sex: All
Age: 0+
Code: NCT05544266
Recruiting
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
for
Solid Tumors, Hematologic Malignancies
Location: Detroit MI, Toronto, Pittsburgh PA, Chicago IL,